日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

纳武利尤单抗联合化疗或伊匹木单抗治疗胃食管癌:一项随机3期试验的探索性生物标志物分析

Shitara, Kohei; Janjigian, Yelena Y; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yañez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming

First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial

一线纳武利尤单抗联合化疗治疗晚期胃癌、胃食管交界处癌和食管腺癌:III期CheckMate 649试验的3年随访

Janjigian, Yelena Y; Ajani, Jaffer A; Moehler, Markus; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Cleary, James M; Elimova, Elena; Karamouzis, Michalis; Bruges, Ricardo; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshi; Tehfe, Mustapha; Zander, Thomas; Kowalyszyn, Ruben; Pazo-Cid, Roberto; Schenker, Michael; Feeny, Kynan; Wang, Rui; Lei, Ming; Chen, Clara; Nathani, Raheel; Shitara, Kohei

Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer

一项开放标签、随机、多中心、III期研究,比较口服紫杉醇联合恩塞奎达与静脉注射紫杉醇治疗转移性乳腺癌患者的疗效

Rugo, Hope S; Umanzor, Gerardo A; Barrios, Francisco J; Vasallo, Rosa H; Chivalan, Marco A; Bejarano, Suyapa; Ramírez, Julio R; Fein, Luis; Kowalyszyn, Ruben D; Kramer, E Douglas; Wang, Hui; Kwan, Min-Fun R; Cutler, David L

Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649

CheckMate 649 研究比较了纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌/胃食管交界处癌或食管腺癌患者的健康相关生活质量。

Moehler, Markus; Xiao, Hong; Blum, Steven I; Elimova, Elena; Cella, David; Shitara, Kohei; Ajani, Jaffer A; Janjigian, Yelena Y; Garrido, Marcelo; Shen, Lin; Yamaguchi, Kensei; Liu, Tianshu; Schenker, Michael; Kowalyszyn, Ruben; Bragagnoli, Arinilda Campos; Bruges, Ricardo; Montesarchio, Vincenzo; Pazo-Cid, Roberto; Hunter, Shannon; Davenport, Eric; Wang, Jinyi; Kondo, Kaoru; Li, Mingshun; Wyrwicz, Lucjan

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

纳武利尤单抗联合化疗一线治疗转移性非小细胞肺癌:III期CheckMate 227第二部分试验结果

Borghaei, H; O'Byrne, K J; Paz-Ares, L; Ciuleanu, T-E; Yu, X; Pluzanski, A; Nagrial, A; Havel, L; Kowalyszyn, R D; Valette, C A; Brahmer, J R; Reck, M; Ramalingam, S S; Zhang, L; Ntambwe, I; Rabindran, S K; Nathan, F E; Balli, D; Wu, Y-L

Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer

纳武利尤单抗联合化疗或伊匹木单抗治疗胃食管癌

Shitara, Kohei; Ajani, Jaffer A; Moehler, Markus; Garrido, Marcelo; Gallardo, Carlos; Shen, Lin; Yamaguchi, Kensei; Wyrwicz, Lucjan; Skoczylas, Tomasz; Bragagnoli, Arinilda Campos; Liu, Tianshu; Tehfe, Mustapha; Elimova, Elena; Bruges, Ricardo; Zander, Thomas; de Azevedo, Sergio; Kowalyszyn, Ruben; Pazo-Cid, Roberto; Schenker, Michael; Cleary, James M; Yanez, Patricio; Feeney, Kynan; Karamouzis, Michalis V; Poulart, Valerie; Lei, Ming; Xiao, Hong; Kondo, Kaoru; Li, Mingshun; Janjigian, Yelena Y

Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study

生物类似药与原研药培非格司亭预防化疗引起的嗜中性粒细胞减少症的比较:一项 III 期随机、多中心、评估者盲法、非劣效性研究

Kowalyszyn, Ruben D; Fein, Luis E; Richardet, Martin E; Varela, Mirta S; Ortiz, Eduardo; Micheri, Cristian; Zarba, Juan J; Kahl, Susana; Klimovsky, Ezequiel; Federico, Andrea A; Cassini, Jorge H; Cortese, Gustavo; Lago, Nestor

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

一线纳武利尤单抗联合化疗与单纯化疗治疗晚期胃癌、胃食管交界处癌和食管腺癌的疗效比较(CheckMate 649):一项随机、开放标签的3期临床试验

Janjigian, Yelena Y; Shitara, Kohei; Moehler, Markus; Garrido, Marcelo; Salman, Pamela; Shen, Lin; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Campos Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Tehfe, Mustapha; Kowalyszyn, Ruben; Karamouzis, Michalis V; Bruges, Ricardo; Zander, Thomas; Pazo-Cid, Roberto; Hitre, Erika; Feeney, Kynan; Cleary, James M; Poulart, Valerie; Cullen, Dana; Lei, Ming; Xiao, Hong; Kondo, Kaoru; Li, Mingshun; Ajani, Jaffer A

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

纳武利尤单抗联合卡博替尼对比舒尼替尼治疗晚期肾细胞癌

Choueiri, Toni K; Powles, Thomas; Burotto, Mauricio; Escudier, Bernard; Bourlon, Maria T; Zurawski, Bogdan; Oyervides Juárez, Victor M; Hsieh, James J; Basso, Umberto; Shah, Amishi Y; Suárez, Cristina; Hamzaj, Alketa; Goh, Jeffrey C; Barrios, Carlos; Richardet, Martin; Porta, Camillo; Kowalyszyn, Rubén; Feregrino, Juan P; Żołnierek, Jakub; Pook, David; Kessler, Elizabeth R; Tomita, Yoshihiko; Mizuno, Ryuichi; Bedke, Jens; Zhang, Joshua; Maurer, Matthew A; Simsek, Burcin; Ejzykowicz, Flavia; Schwab, Gisela M; Apolo, Andrea B; Motzer, Robert J

Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4)

依维莫司二线治疗转移性肾细胞癌患者的 II 期试验 (RECORD-4)

Motzer, R J; Alyasova, A; Ye, D; Karpenko, A; Li, H; Alekseev, B; Xie, L; Kurteva, G; Kowalyszyn, R; Karyakin, O; Neron, Y; Cosgriff, T; Collins, L; Brechenmacher, T; Lin, C; Morgan, L; Yang, L